Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

By  

ALLERGY, Vol. 105-4538, Iss. 10, 2015-10 ,pp. : 1319-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

By  

ALLERGY, Vol. 70, Iss. 10, 2015-10 ,pp. : 1319-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Challenges of C1-Inhibitor Concentrate Self-Administration

By  

International Archives of Allergy and Immunology, Vol. 161, Iss. 1, 2013-05 ,pp. : 21-25

Karger

Access to resources Recommend Favorite

Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis

By Konstan Michael W   Borowitz Drucy   Mayer-Hamblett Nicole   Milla Carlos   Hendeles Leslie   Murray Susan   Kronmal Richard A   Casey Susan   Rose Lynn M   Morgan Wayne J   Ramsey Bonnie W  

Clinical Investigation, Vol. 3, Iss. 8, 2013-08 ,pp. : 731-741

Future Science

Access to resources Recommend Favorite

Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis

By Konstan Michael W   Accurso Frank J   Nasr Samya Z   Ahrens Richard C   Graff Gavin R  

Clinical Investigation, Vol. 3, Iss. 8, 2013-08 ,pp. : 723-729

Future Science

Access to resources Recommend Favorite